CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: Compared to healthy BM, CXCL12 levels on mesenchymal stem cells in the BM microenvironment in CML are decreased, resulting in a reduced LSC-retention in the BM and egress to the circulation [22, 53].